Professional Medical Expertise Company (TADAWUL:9574)
Saudi Arabia
· Delayed Price · Currency is SAR 97.50
+3.15 (3.34%)
At close: Dec 4, 2025
TADAWUL:9574 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 355.81 | 313.17 | 250.12 | 176.05 | 131.26 | 74.42 |
| Revenue Growth (YoY) | 27.67% | 25.21% | 42.07% | 34.13% | 76.39% | - |
| Cost of Revenue | 194.56 | 174.37 | 138.15 | 92.4 | 64.35 | 34.62 |
| Gross Profit | 161.26 | 138.8 | 111.96 | 83.65 | 66.91 | 39.8 |
| Selling, General & Admin | 108.49 | 95.65 | 76.1 | 55.35 | 42.02 | 27.65 |
| Operating Expenses | 112.14 | 99.45 | 78.9 | 57.75 | 42.46 | 28.15 |
| Operating Income | 49.12 | 39.35 | 33.07 | 25.9 | 24.45 | 11.65 |
| Interest Expense | -11.69 | -10.82 | -6.65 | -0.1 | - | - |
| Currency Exchange Gain (Loss) | -1.27 | -1.27 | -0.57 | - | - | - |
| Other Non Operating Income (Expenses) | 2.53 | 1.3 | 0.27 | -4.93 | -2.64 | -1.64 |
| EBT Excluding Unusual Items | 38.7 | 28.57 | 26.12 | 20.87 | 21.81 | 10 |
| Gain (Loss) on Sale of Assets | 1.44 | 1.44 | 1.09 | - | - | - |
| Pretax Income | 40.14 | 30 | 27.22 | 20.87 | 21.81 | 10 |
| Income Tax Expense | 2.5 | 2.36 | 2.37 | 1.85 | 1.19 | 0.71 |
| Earnings From Continuing Operations | 37.63 | 27.64 | 24.84 | 19.02 | 20.62 | 9.3 |
| Minority Interest in Earnings | 0.01 | 0.01 | -0 | - | - | - |
| Net Income | 37.65 | 27.65 | 24.84 | 19.02 | 20.62 | 9.3 |
| Net Income to Common | 37.65 | 27.65 | 24.84 | 19.02 | 20.62 | 9.3 |
| Net Income Growth | 35.47% | 11.29% | 30.65% | -7.78% | 121.80% | - |
| Shares Outstanding (Basic) | 4 | 4 | 4 | 2 | 1 | - |
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 2 | 1 | - |
| Shares Change (YoY) | - | - | 56.73% | 189.51% | - | - |
| EPS (Basic) | 10.76 | 7.90 | 7.10 | 8.52 | 26.73 | - |
| EPS (Diluted) | 10.76 | 7.90 | 7.10 | 8.52 | 26.73 | - |
| EPS Growth | 35.47% | 11.29% | -16.64% | -68.14% | - | - |
| Free Cash Flow | -1.3 | -8.46 | -3.1 | -10.43 | 17.69 | 9.93 |
| Free Cash Flow Per Share | -0.37 | -2.42 | -0.89 | -4.67 | 22.93 | - |
| Dividend Per Share | 1.000 | 1.000 | - | - | - | - |
| Gross Margin | 45.32% | 44.32% | 44.77% | 47.51% | 50.98% | 53.48% |
| Operating Margin | 13.80% | 12.57% | 13.22% | 14.71% | 18.63% | 15.65% |
| Profit Margin | 10.58% | 8.83% | 9.93% | 10.80% | 15.71% | 12.49% |
| Free Cash Flow Margin | -0.36% | -2.70% | -1.24% | -5.93% | 13.48% | 13.35% |
| EBITDA | 54.49 | 44.25 | 37.06 | 27.96 | 26.25 | 13.26 |
| EBITDA Margin | 15.31% | 14.13% | 14.82% | 15.88% | 20.00% | 17.82% |
| D&A For EBITDA | 5.37 | 4.89 | 3.99 | 2.06 | 1.79 | 1.62 |
| EBIT | 49.12 | 39.35 | 33.07 | 25.9 | 24.45 | 11.65 |
| EBIT Margin | 13.80% | 12.57% | 13.22% | 14.71% | 18.63% | 15.65% |
| Effective Tax Rate | 6.24% | 7.87% | 8.72% | 8.88% | 5.46% | 7.07% |
Source: S&P Capital IQ. Standard template. Financial Sources.